森松國際(02155.HK)全球發售不予進行
格隆匯3月12日丨森松國際(02155.HK)發佈公吿,由於公司需要更多時間迴應監管機構的查詢,以取得監管機構批准刊發載有有關最終發售價、國際配售的踴躍程度及香港公開發售的申請水平的公吿,公司決定全球發售現階段將不予進行。
於2021年3月12日,公司向使用黃色及白色申請表格、網上白表服務及透過中央結算系統向香港結算髮出電子認購指示的申請人作出金額為最高發售價與2.58港元(即於定價日決定的發售價)之間的差額的部分退款以及全部或部分不成功的申請人(根據當時暫定分配結果)的全額退款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.